Clinical Trial Update: Effect of IV Infusion of Lidocaine Compared to IV Infusion of Dexmedetomidine on Proinflammatory Cytokines [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intravenous lidocaine versus dexmedetomidine on proinflammatory cytokines for an inflammatory response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Response

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)
• Lidocaine (Lidocaine)

Snippet

Sponsor: Norma Osama Abdalla Zayed | Conditions: Inflammatory Response | Phase 3 | Status: COMPLETED